These 10 Stocks Are On Fire Right Now
Today's best performers were dominated anew by stocks riding the Artificial Intelligence boom.
Insider Monkey Blog
Piper Sandler Boosts TransMedics (TMDX) PT to $145, Keeps Overweight Rating
On Wednesday, Piper Sandler analyst Matt O’Brien raised the price target on TransMedics Group Inc.
JPMorgan Elevates Amazon (AMZN) PT to $240 on Strong Q1 Report
On Wednesday, JPMorgan analyst Doug Anmuth raised the price target for Amazon.com Inc. (NASDAQ:AMZN) to $240 from $225, while maintaining an Overweight rating on the shares.
UBS Raises BBB Foods (TBBB) PT to $33, Keeps Neutral Rating
On Wednesday, UBS raised its price target for BBB Foods Inc. (NYSE:TBBB) from $32 to $33, while maintaining a Neutral rating on the company's shares.
UBS Raises Ambev (ABEV) PT to $2.70, Keeps Neutral Rating
On Wednesday, UBS raised its price target for Ambev (NYSE:ABEV) from $2.60 to $2.70, while maintaining a Neutral rating on the shares.
Morgan Stanley Boosts Couchbase (BASE) PT to $19 Following Strong Q1 Report
On Wednesday, Morgan Stanley analyst Sanjit Singh raised the price target for Couchbase Inc.
Evercore ISI Downgrades CrowdStrike (CRWD) to In Line, Cuts PT
On Wednesday, Evercore ISI downgraded the rating for CrowdStrike Holdings Inc. (NASDAQ:CRWD) from Outperform to In Line. The price target was also reduced from $450 to $440.
Cardinal Health Unveils Kendall DL Multi System for Integrated Patient Monitoring
On Wednesday, Cardinal Health Inc. (NYSE:CAH) announced the US launch of its new Kendall DL Multi System.
Louisiana-Pacific Corporation, BlueLinx Holdings Expand Distribution Partnership
On June 2, Louisiana-Pacific Corporation (NYSE:LPX) and BlueLinx Holdings Inc. (NYSE:BXC) announced the expansion of their distribution partnership to Springfield, Missouri.
BMO Capital Maintains Buy Rating on Corpay (CPAY), Keeps PT
On June 3, BMO Capital’s analyst Rufus Hone reiterated a Buy rating on Corpay Inc. (NYSE:CPAY), with an unchanged price target of $410.
Needham Says Promising Data Underscore Growth Potential for Jazz Pharma (JAZZ)
On June 3, Needham analyst Ami Fadia reaffirmed a Buy rating on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and raised the price target slightly from $200 to $202.
BMO Maintains Hold on BridgeBio (BBIO) Amid Intensifying Competition
On June 3, BMO Capital Markets analyst Kostas Biliouris reiterated a Hold rating on BridgeBio Pharma Inc. (NASDAQ:BBIO) with an unchanged price target of $37.
Jefferies Thinks Lululemon’s (LULU) Growth Story Remains Under Strain, Maintains Sell Rating
On June 3, Jefferies analyst Randal Konik reiterated a Sell rating on Lululemon Athletica Inc. (NASDAQ:LULU) and maintained his price target of $220.
Needham Downgrades Apple (AAPL), Flags $170–$180 as Attractive Entry Level
On Wednesday, Needham analyst Laura Martin downgraded Apple Inc. (NASDAQ:AAPL) to Hold from Buy without assigning any price target.
Chart Industries (GTLS) and Flowserve to Merge in $19 Billion All-Stock Deal
On Wednesday, Chart Industries Inc.
Goldman Sees Strong Utility Tailwinds for Quanta (PWR), Hikes Price Target to $414
On June 3, Goldman Sachs analyst Atidrip Modak raised the price target on Quanta Services Inc. (NYSE:PWR) from $364 to $414, while maintaining a Buy rating.
Bernstein Initiates Coverage of Spotify (SPOT) With an Outperform Rating
On June 3, Bernstein analyst Ian Moore initiated coverage on Spotify Technology S.A. (NYSE:SPOT) with an Outperform rating and assigned a price target of $825.
10 Buzzing AI Stocks on Latest News and Ratings
Wedbush analyst Dan Ives is taking a definitive step to validate his faith in AI. On Wednesday, Wedbush Fund Advisers launched the Dan IVES Wedbush AI Revolution ETF.
Goldman Sachs Raises Li Auto (LI) PT After Solid Q1 Report
Tina Hou from Goldman Sachs made the price target upgrade after the company’s gross profit and GAAP net profit exceeded Hou's estimates by 6% and 21%, respectively, driven by...
Mizuho Lowers Nio Inc. (NIO) PT, Maintains Neutral Rating
Vijay Rakesh from Mizuho made the update following Nio’s first quarter 2025 results.
Brookfield Plans to Invest $9.9 billion to Build AI Data Center in Sweden
The data center is expected to create 1,000 new permanent jobs and nearly 2,000 jobs over the 10-15 year construction process.
Cantor Fitzgerald Initiates Coverage of Sprout Social (SPT) With Neutral Rating
Brett Knoblauch from Cantor Fitzgerald noted that the company is gaining market share in the Social Media Management sector.
JPMorgan Downgrades Rating on Bumble (BMBL) Amid Revenue Pressure
JPM Analyst, Cory Carpenter, noted that while the company’s shares surged over 50% since its restructuring fiasco, the surge was likely driven by cost cuts rather than sustainable...
Fresh Del Monte (FDP) Launches Its Premium Pinkglow Apple in UAE
From June 4, consumers in the UAE will be able to purchase Pinkglow on the e-commerce platform, Talabat.
UBS Raises PT on Netflix (NFLX) Amid Strong Trends, Keeps Buy Rating
UBS analyst John Hodulik increased the price target for NFLX stock, citing the company’s strong viewership and a favorable industry backdrop.
Leerink Raises Genmab (GMAB) Price Target, Keeps Outperform Rating
The decision came after Genmab A/S (NASDAQ:GMAB) shared new data on Rina-S in second-line and endometrial cancer treatments at the American Society of Clinical Oncology (ASCO) ...
UBS Lowers Berkshire Hathaway (BRK-A) Price Target, Keeps Buy Rating
The reduced price target reflects slightly lower earnings per share (EPS) estimates, mainly due to a lower projection for investment income.
Piper Sandler Raises Lululemon (LULU) Price Target, Keeps Neutral Rating
On Tuesday, June 3, Piper Sandler analysts raised the price target on Lululemon Athletica Inc. (NASDAQ:LULU) from $280 to $315 and kept a “Neutral” rating.
Truist Keeps Buy Rating on Alphabet (GOOGL), Sees Value in Key Brands
While Alphabet Inc.
UBS Keeps Buy Rating on NVIDIA, Sees Huge Revenue Potential
The firm’s analysts highlighted NVIDIA Corporation’s (NASDAQ:NVDA) strong potential in the data center sector, especially because of its upcoming large AI infrastructure projects...
Evercore Maintains Outperform Rating on Apple (AAPL), Expects Small Updates at WWDC
Analysts expect this year’s Worldwide Developers Conference (WWDC) by Apple Inc.
10 Stock Predictions That Jim Cramer Got Right Again
During the most recent episode of Mad Money, Jim Cramer opened with a candid admission about the current state of the stock market, expressing frustration at how poorly it’s...
Jim Cramer’s Thoughts on These 12 Stocks
On Tuesday’s episode of Mad Money, host Jim Cramer expressed concern over how President Donald Trump's actions have been impacting the stock market as he pointed out the confusion...
Mastercard (MA) and PayPal (PYPL) Team Up to Enhance Payment Choices
Mastercard Inc. (NYSE:MA) and PayPal Holdings, Inc. (NASDAQ:PYPL) are collaborating to enhance payment flexibility for shoppers.
Franklin Resources (BEN) Expands European Presence with Apera Acquisition
Franklin Resources, Inc. (NYSE:BEN) has reiterated its commitment to expanding its global alternative platform and direct lending capabilities across Europe.
Truist Securities Reaffirms Buy Rating on CrowdStrike (CRWD) After Strong Q1 Results
On June 3, Truist Securities analysts reiterated a ‘Buy’ rating for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) stock and maintained a $450 price target.
Citi Downgrades Constellation Energy (CEG) to Neutral, Raises Price Target to $318
On June 4, analysts at Citi downgraded Constellation Energy Corporation (NASDAQ:CEG) to a ‘Neutral’ from a ‘Buy.’ The downgrade comes after a big rise in the company’...
JPMorgan Raises Booking Holdings (BKNG) Price Target on Strong Competitive Advantage
On June 4, JPMorgan lifted its price target to $6,000 from $5,360 for Booking Holdings Inc. (NASDAQ:BKNG) stock. The firm maintained an ‘Overweight’ rating on the shares.
JPMorgan Lifts Meta Price Target on AI and Metaverse Investments
One of the factors the analysts emphasized as having influenced their decision is Meta’s dominant position in the social media landscape.
JPMorgan Raises Duolingo (DUOL) Price Target as Growth Accelerates
On June 4, JPMorgan analysts raised their price target for Duolingo Inc. (NASDAQ:DUOL) from $500 to $580 while keeping an Overweight rating.
Citi Raises Western Digital Price (WDC) Target to $62, Reiterates Buy Rating
On June 3, Citi analysts increased the price target for Western Digital Corporation (NASDAQ:WDC) stock to $62 from $56 while reiterating a 'Buy' rating.
JPMorgan Raises Etsy’s (ETSY) Price Target Amid Strong Marketplace Performance
On June 4, JPMorgan analysts increased their price target for Etsy, Inc. (NASDAQ:ETSY) to $50 from $42 while maintaining a ‘Neutral’ rating.
UBS Upgrades Snowflake (SNOW) Amid AI-Driven Growth Prospects
On June 4, UBS upgraded Snowflake Inc. (NYSE:SNOW) stock to a ‘Buy’ from a Neutral and raised the price target to $265 from $210.
RBC Capital Raises Snowflake (SNOW) Price Target, Maintains Outperform Rating
RBC Capital has raised its price target on Snowflake Inc.
JPMorgan Maintains Overweight Rating on Broadcom (AVGO) Stock
[caption id="attachment_1230458" align="aligncenter" width="1456"] A leading semiconductor chip on a computer robot arm, reflecting the technology advances of the company.[/caption...
TD Cowen Reiterates ‘Buy’ Rating for Apple (AAPL) with a $275 Price Target
On June 3, analysts at TD Cowen reaffirmed a 'Buy' rating and a $275 price target on Apple Inc. (NASDAQ:AAPL) stock.
Cyberwrite Expands Partnership with Markel to Enhance Cyber Risk Underwriting
On June 3, Cyberwrite, a cyber risk modeling technology provider, said it had expanded its partnership with Markel Group Inc. (NYSE:MKL).
TD Cowen Reiterates ‘Hold’ Rating on Campbell Soup (CPB) on Earnings Beat
On June 3, analysts at TD Cowen reiterated a Hold rating and a $36 price target on Campbell Soup (NASDAQ:CPB).
TD Cowen Reiterates’ Buy’ Rating on General Motors (GM) on Improving US Auto Sales
On June 3, TD Cowen analysts reiterated a Buy rating on General Motors Company (NYSE:GM) stock and maintained an $83 price target.
Takeda Reports Adcetris Combo Approved by EC for Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (NYSE:TAK)'s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized by the European Commission on June 3, 2025, for newly...
Hedge Fund Resource Center
